E-LIB Suche - Ergebnisse für: Monk, Bradley

1

Patterns of initial ovarian cancer recurrence on niraparib ..:

Kamrava, Mitchell R. ; Gonzalez-Martin, Antonio ; Pothuri, Bhavana...
Gynecologic Oncology. 189 (2024) - p. 68-74 , 2024

Link: https://doi.org/10.1016/..

2

Immunotherapy in locally advanced cervix cancer: A critical..:

Monk, Bradley J. ; Tewari, Krishnansu S. ; Randall, Leslie M....
Gynecologic Oncology. 188 (2024) - p. 81-82 , 2024

Link: https://doi.org/10.1016/..

3

Preoperative and pre-chemotherapy CA-125 levels in high-ris..:

Chan, John K. ; Tian, Chunqiao ; Kesterson, Joshua P....
Gynecologic Oncology. 181 (2024) - p. 54-59 , 2024

Link: https://doi.org/10.1016/..

4

Health-related quality of life in patients with newly diagn..:

Pothuri, Bhavana ; Han, Sileny ; Chase, Dana M....
Gynecologic Oncology. 184 (2024) - p. 168-177 , 2024

Link: https://doi.org/10.1016/..

5

Niraparib Population Pharmacokinetics and Exposure-Response..:

Monk, Bradley J. ; Romero, Ignacio ; Graybill, Whitney...
Clinical Therapeutics. 46 (2024) 8 - p. 612-621 , 2024

Link: https://doi.org/10.1016/..

6

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

7

Response to Alexandre Andre B A da Costa et al:

Monk, Bradley J. ; Coleman, Robert L. ; Tewari, Krishnansu S....
Gynecologic Oncology. 189 (2024) - p. 146-147 , 2024

Link: https://doi.org/10.1016/..

8

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized,..:

Vergote, Ignace ; Perez Fidalgo, Alejandro ; Valabrega, Giorgio...
International Journal of Gynecologic Cancer. 34 (2024) 8 - p. 1283-1289 , 2024

Link: https://doi.org/10.1136/..

9

A plain language summary of publication of the efficacy and..:

Mirza, Mansoor R ; González-Martín, Antonio ; Graybill, Whitney S...
Future Oncology. 20 (2024) 13 - p. 799-809 , 2024

Link: https://doi.org/10.2217/..

10

Paclitaxel therapeutic drug monitoring - International asso..:

Hertz, Daniel L. ; Joerger, Markus ; Bang, Yung-Jue...
European Journal of Cancer. 202 (2024) - p. 114024 , 2024

Link: https://doi.org/10.1016/..

11

CALLA trial: immunotherapy in locally advanced cervical can..:

Monk, Bradley J ; Mayadev, Jyoti
The Lancet Oncology. 25 (2024) 3 - p. e96 , 2024

Link: https://doi.org/10.1016/..

12

Biomarker guidance in selection among breakthrough treatmen..:

Chan, John K. ; Tewari, Krishnansu ; Monk, Bradley J....
Gynecologic Oncology. 187 (2024) - p. 249-252 , 2024

Link: https://doi.org/10.1016/..

13

Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted ..:

Nemunaitis, John ; Stanbery, Laura ; Walter, Adam...
Future Oncology. , 2024

Link: https://doi.org/10.1080/..

14

Tolerability of the niraparib individualized starting dose ..:

Vulsteke, Christof ; Chambers, Setsuko K. ; Pérez, Maria Jesús Rubio...
European Journal of Cancer. 208 (2024) - p. 114157 , 2024

Link: https://doi.org/10.1016/..

15

A systematic review of stage IVA cervical cancer treatment:..:

Hunsberger, Kyra S. ; Treiman, Sierra ; Monk, Bradley J....
Gynecologic Oncology. 187 (2024) - p. 120-127 , 2024

Link: https://doi.org/10.1016/..